Clinical Trial Update: Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lurbinectedin with or without avelumab in small cell carcinoma of the bladder and high-grade neuroendocrine tumors of the urin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Neuroendocrine Tumors of the Urinary Tract
• Small Cell Carcinoma of the Bladder

Drugs mentioned

• BAVENCIO (AVELUMAB)
• Zepzelca (lurbinectedin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Small Cell Carcinoma of the Bladder, High Grade Neuroendocrine Tumors of the Urinary Tract | Phase 2 | Status: RECRUITING